Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

9.69
-0.6900-6.65%
Post-market: 9.690.00000.00%19:09 EST
Volume:5.54K
Turnover:54.99K
Market Cap:8.89M
PE:-0.04
High:10.21
Open:10.20
Low:9.65
Close:10.38
52wk High:265.86
52wk Low:6.08
Shares:916.97K
Float Shares:832.40K
Volume Ratio:0.21
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-236.5200
EPS(LYR):-1,317.4218
ROE:-1763.01%
ROA:-232.54%
PB:6.23
PE(LYR):-0.01

Loading ...

Transcode Therapeutics Inc - Completes Phase 1a Trial With Ttx-Mc138 in Metastatic Disease at Esmo- SEC Filing

THOMSON REUTERS
·
Oct 14, 2025

Transcode Therapeutics Inc - Safety Primary Endpoint Achieved in Phase 1a Trial - SEC Filing

THOMSON REUTERS
·
Oct 14, 2025

TransCode Therapeutics Advances TTX-MC138 to Phase 2a Trials After Positive Phase 1a Results in Metastatic Disease

Reuters
·
Oct 14, 2025

Transcode Therapeutics Issues Correction to Series B Preferred Stock Price in SEC Filing

Reuters
·
Oct 09, 2025

TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout

Benzinga_recent_news
·
Oct 08, 2025

TransCode Therapeutics Acquires Polynoma and Secures Investment

TIPRANKS
·
Oct 08, 2025

Transcode Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
Oct 08, 2025

Transcode Therapeutics to acquire Polynoma

TIPRANKS
·
Oct 08, 2025

TransCode Therapeutics acquires Polynoma and secures 25 million investment from CK Life Sciences

Reuters
·
Oct 08, 2025

Transcode Therapeutics Inc - Concurrent Equity Investment of $25 Mln From CK Life Sciences Into Transcode

THOMSON REUTERS
·
Oct 08, 2025

Transcode Therapeutics Inc: Philippe Calais Appointed as Transcode's Chief Executive Officer and Remains Chairman

THOMSON REUTERS
·
Oct 08, 2025

Transcode Therapeutics (Rnaz) Announces the Acquisition of Polynoma and a $25 Million Strategic Financing by a Subsidiary of CK Life Sciences to Form a First-in-Class Unique Immuno-Oncology and Metastatic Prevention Oncology Company

THOMSON REUTERS
·
Oct 08, 2025

TransCode Therapeutics Amends Patent License Agreement with Massachusetts General Hospital, Increases Milestone Payments

Reuters
·
Oct 04, 2025

Transcode Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Sep 03, 2025